Deborah Gordon, Vice-Chair of the Corporate Department and the Co-Chair of the Healthcare Practice Group of Seyfarth Shaw LLP, concentrates her practice in mergers and acquisitions with a specialization in the health care industry and healthcare regulatory compliance and restrictions. Ms. Gordon regularly structures various types of lending, investment, and equity transactions, such as asset-based, cash-flow and real estate loan transactions, leveraged buyouts, mezzanine financing, convertible security issuances, workouts, venture capital transactions, warrants, private placements, divestitures, joint ventures, supply agreements, license agreements, distribution agreements, purchasing agreements, wholesaler agreements, clinical trial agreements, collaborative research agreements, employment agreements, compliance plans, and outsourcing arrangements.  Ms, Gordon is also a frequent lecturer and author on healthcare transactions and regulatory matters.

Ms. Gordon actively counsels and represents general corporate and health care clients, including pharmaceutical companies, medical device companies, biotech companies, health care providers, HMOs, PPOs, long term care facilities, hospitals, surgical centers, physician associations and physician groups. She also advises borrowers and lenders in commercial and real estate finance transactions, syndications, loan acquisitions, and participations, particularly in the health care and pharmaceutical industry. In particular, Ms. Gordon focuses on distressed debt and workouts of health care facilities.

Ms. Gordon regularly advises health care clients on fraud and abuse, self-referral prohibitions, pharmaceutical pricing issues (including rebates, discounts and price reporting), corporate practice of medicine, fee splitting, compliance, privacy, HIPAA, false claims, antitrust, managed care, licensing, certificate of need, and other health care regulatory issues, including those contained in the Patient Protection and Affordable Care Act.

Ms. Gordon has earned her Green Belt certificate in the firm’s Six Sigma program, and is a member of the firm's Health Reform Team.  This cross-departmental team of lawyers was formed to focus on how health care reform will affect our clients.

Deborah Gordon, Vice-Chair of the Corporate Department and the Co-Chair of the Healthcare Practice Group of Seyfarth Shaw LLP, concentrates her practice in mergers and acquisitions with a specialization in the health care industry and healthcare regulatory compliance and restrictions. Ms. Gordon regularly structures various types of lending, investment, and equity transactions, such as asset-based, cash-flow and real estate loan transactions, leveraged buyouts, mezzanine financing, convertible security issuances, workouts, venture capital transactions, warrants, private placements, divestitures, joint ventures, supply agreements, license agreements, distribution agreements, purchasing agreements, wholesaler agreements, clinical trial agreements, collaborative research agreements, employment agreements, compliance plans, and outsourcing arrangements.  Ms, Gordon is also a frequent lecturer and author on healthcare transactions and regulatory matters.

Ms. Gordon actively counsels and represents general corporate and health care clients, including pharmaceutical companies, medical device companies, biotech companies, health care providers, HMOs, PPOs, long term care facilities, hospitals, surgical centers, physician associations and physician groups. She also advises borrowers and lenders in commercial and real estate finance transactions, syndications, loan acquisitions, and participations, particularly in the health care and pharmaceutical industry. In particular, Ms. Gordon focuses on distressed debt and workouts of health care facilities.

Ms. Gordon regularly advises health care clients on fraud and abuse, self-referral prohibitions, pharmaceutical pricing issues (including rebates, discounts and price reporting), corporate practice of medicine, fee splitting, compliance, privacy, HIPAA, false claims, antitrust, managed care, licensing, certificate of need, and other health care regulatory issues, including those contained in the Patient Protection and Affordable Care Act.

Ms. Gordon has earned her Green Belt certificate in the firm’s Six Sigma program, and is a member of the firm's Health Reform Team.  This cross-departmental team of lawyers was formed to focus on how health care reform will affect our clients.